Immunic, Inc. (IMUX) Operating cash flow 2016–2025
Immunic, Inc. (IMUX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$85.8MFY2025 · since FY2016: -$35.8M → -$85.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.8M | -1.2% |
| FY2024 | -$84.8M | -19.7% |
| FY2023 | -$70.8M | -8.7% |
| FY2022 | -$65.1M | +21.7% |
| FY2021 | -$83.2M | -80.5% |
| FY2020 | -$46.1M | -61.6% |
| FY2019 | -$28.5M | -193.1% |
| FY2018 | -$9.7M | +75.9% |
| FY2017 | -$40.4M | -12.9% |
| FY2016 | -$35.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice